This invention relates to novel 2-substituted-6-biarylmethylamino-9-cyclopentyl-9H-purine derivatives, showing activity as specific inhibitors of growth and angiogenesis of hepatocellular carcinoma. The invention further includes pharmaceutical compositions containing the 2-substituted-6-biarylmethylamino-9-cyclopentylpurines.
本发明涉及新颖的2-取代-6-双芳基甲
氨基-9-环戊基-9H-
嘌呤衍
生物,显示出作为肝细胞癌生长和血管生成特异性
抑制剂的活性。本发明进一步包括含有这些2-取代-6-双芳基甲
氨基-9-环戊基
嘌呤的药物组合物。